Results 221 to 230 of about 118,013 (268)

Single Ascending-Dose Study of Selective ErbB4 Agonist JK07 in Heart Failure With Reduced Ejection Fraction. [PDF]

JACC Basic Transl Sci
Tang WHW, Steiner J, Kassi M, Wheeler MT, Spahillari A, Sweitzer NK, Grodin JL, Solomon N, Singhal S, McEwen AMG, Murphy SL.   +10 more
europepmc   +1 more source

Nurse Specialising Consultation in Heart Failure: Impact on Drug Titration and Cardiovascular Events in Patients with Heart Failure and Reduced Ejection Fraction. [PDF]

J Clin Med
Lopez-Aguilera J, Perea-Armijo J, Muñoz-Villarreal AB, Cepas-Sosa A, Luque-Serrano LM, Aguayo-Caño N, Heredia-Campos GM, Martin-Diaz JD, Gonzalez-Manzanares R, Castillo-Dominguez JC, Crespin-Crespin M, Delgado-Ortega M, Ruiz-Ortiz M, Mesa-Rubio D, Pan-Alvarez Osorio M, Anguita-Sanchez M.   +15 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Flecainide Toxicity Leading to Transient Heart Failure With Reduced Ejection Fraction: A Case Study. [PDF]

Cureus
Wolchover T, Pourafkari L, Dev V, Takher J.   +3 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Incidence and determinants of left ventricular ejection fraction (LVEF) recovery in heart failure with reduced ejection fraction (HFrEF) of non-ischemic aetiology; a hospital-based prospective longitudinal registry study

Sanjeev Kumar, Prakash Chand Negi, Sanjeev Asotra, Jitender Kumar, Rajeev Merwah, Rajesh Sharma, Ritesh Kumar, Vinay Bhardwaj, Pradeep Kumar Thakur   +8 more
openalex   +1 more source

Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study. [PDF]

Lancet Reg Health Eur
Svanström H, Mkoma GF, Hviid A, Pasternak B.   +3 more
europepmc   +1 more source

Improving the Management of Patients with Heart Failure with Reduced Ejection Fraction in Clinical Practice: The Case for Angiotensin Receptor-Neprilysin Inhibitor. [PDF]

Card Fail Rev
Iacoviello M, Maria Sarullo F, Bilato C, Correale M, Di Gesaro G, Driussi M, Passantino A, Villani A, Di Lenarda A.   +8 more
europepmc   +1 more source